Clinical Trial

Postoperative Adjuvant Therapy for CT041 Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma Patients

Name: Postoperative Adjuvant Therapy for CT041 Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma Patients — clinical trial record (NCT06857786)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: CT041-CG4010

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

To evaluate the safety and tolerability of satri-cel as consolidation therapy after postoperative adjuvant therapy in patients with resected gastric or gastroesophageal junction (G/GEJ) adenocarcinoma

Trial Details

NCT Number	NCT06857786
Lead Sponsor	Peking University
Conditions	Gastroesophageal Junction Adenocarcinoma, Gastric Adenocarcinoma
Enrollment	48 participants
Start Date	2025-03-10
Primary Completion	2027-06-30 (estimated)
Study Completion	2030-06-30 (estimated)
Updated on ClinicalTrials.gov	2025-03-04